Authors: Ferenci, P Stauber, R Steindl-Munda, P Gschwantler, M Fickert, P Datz, C Muller, C Hackl, F Rainer, W Watkins-Riedel, T Lin, W Krejs, GJ Gangl, A

Citation: P. Ferenci et al., Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial, EUR J GASTR, 13(6), 2001, pp. 699-705

Authors: Ferenci, P Brunner, H Nachbaur, K Datz, C Gschwantler, M Hofer, H Stauber, R Hackl, F Jessner, W Rosenbeiger, M Munda-Steindl, P Hegenbarth, K Gangl, A Vogel, W

Citation: P. Ferenci et al., Combination of interferon induction therapy and ribavirin in chronic hepatitis C, HEPATOLOGY, 34(5), 2001, pp. 1006-1011

Authors: Ferenci, P Stauber, R Steindl-Munda, P Gschwantler, M Fickert, P Datz, C Muller, C Hackl, F Rainer, W Watkins-Riedel, T Lin, W

Citation: P. Ferenci et al., Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon-alpha in interferon nonresponders with chronichepatitis C, J VIRAL HEP, 6, 1999, pp. 53-58

Authors: Kazemi-Shirazi, L Datz, C Maier-Dobersberger, T Kaserer, K Hackl, F Polli, C Steindl, PE Penner, E Ferenci, P

Citation: L. Kazemi-shirazi et al., The relation of iron status and hemochromatosis gene mutations in patientswith chronic hepatitis C, GASTROENTY, 116(1), 1999, pp. 127-134

Authors: Hackl, F Pruckner, GJ

Citation: F. Hackl et Gj. Pruckner, On the gap between payment card and closed-ended CVM-answers, APPL ECON, 31(6), 1999, pp. 733-742